Furosemide analogues as potent inhibitors of the new permeability pathways of Plasmodium falciparum -infected human erythrocytes
-
Altmetric Citations
Staines, Henry M; Dee, Belinda C; O'Brien, Martin; Lang, Hans-Jochen; Englert, Heinrich; Horner, Heather A; Ellory, J Clive; Kirk, Kiaran
dc.contributor.author | Staines, Henry M | |
---|---|---|
dc.contributor.author | Dee, Belinda C | |
dc.contributor.author | O'Brien, Martin | |
dc.contributor.author | Lang, Hans-Jochen | |
dc.contributor.author | Englert, Heinrich | |
dc.contributor.author | Horner, Heather A | |
dc.contributor.author | Ellory, J Clive | |
dc.contributor.author | Kirk, Kiaran | |
dc.date.accessioned | 2015-12-13T22:51:29Z | |
dc.date.available | 2015-12-13T22:51:29Z | |
dc.identifier.issn | 0166-6851 | |
dc.identifier.uri | http://hdl.handle.net/1885/81105 | |
dc.publisher | Elsevier | |
dc.source | Molecular and Biochemical Parasitology | |
dc.subject | Keywords: anion; antiprotozoal agent; bumetanide; choline; clomifene; furosemide; h 105; h 106; h 120; h 131; h 156; h 157; h 158; h 159; h 18; h 19; h 59; mefloquine; tamoxifen; unclassified drug; anion transport; article; controlled study; dose response; drug eff Channel; Choline; Erythrocyte; Malaria; Membrane; Transport | |
dc.title | Furosemide analogues as potent inhibitors of the new permeability pathways of Plasmodium falciparum -infected human erythrocytes | |
dc.type | Journal article | |
local.description.notes | Imported from ARIES | |
local.description.refereed | Yes | |
local.identifier.citationvolume | 133 | |
dc.date.issued | 2004 | |
local.identifier.absfor | 060502 - Infectious Agents | |
local.identifier.absfor | 060110 - Receptors and Membrane Biology | |
local.identifier.absfor | 111501 - Basic Pharmacology | |
local.identifier.ariespublication | MigratedxPub9442 | |
local.type.status | Published Version | |
local.contributor.affiliation | Staines, Henry M, University of London | |
local.contributor.affiliation | Dee, Belinda C, Oxford University | |
local.contributor.affiliation | O'Brien, Martin, Oxford University | |
local.contributor.affiliation | Lang, Hans-Jochen, Aventis Pharma Deutschland GmbH | |
local.contributor.affiliation | Englert, Heinrich, Aventis Pharma Deutschland GmbH | |
local.contributor.affiliation | Horner, Heather A, Oxford University | |
local.contributor.affiliation | Ellory, J Clive, Oxford University | |
local.contributor.affiliation | Kirk, Kiaran, College of Medicine, Biology and Environment, ANU | |
local.bibliographicCitation.issue | 2 | |
local.bibliographicCitation.startpage | 315 | |
local.bibliographicCitation.lastpage | 318 | |
local.identifier.doi | 10.1016/j.molbiopara.2003.10.009 | |
dc.date.updated | 2015-12-11T10:45:31Z | |
local.identifier.scopusID | 2-s2.0-0347418183 | |
Collections | ANU Research Publications |
Download
There are no files associated with this item.
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.
Updated: 19 May 2020/ Responsible Officer: University Librarian/ Page Contact: Library Systems & Web Coordinator